GB-920

N/A

Report date: 2024/12/18 13:39:48

NME

Base Information

Drug NameGB-920

Drug Alias NameGB-920

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionGalactoside-binding lectin Galectin 9 modulators

TargetsGalactoside-binding lectin Galectin 9

Therapy Area/IndicationsPancreatic NeoplasmsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGbioLogics Inc

China Registration ClassN/A

Active CompaniesGbioLogics Inc

Inactive CompaniesN/A

Active IndicationsPancreatic NeoplasmsColorectal Neoplasms

Inactive IndicationsN/A

ATC CodeN/A